• Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Indacaterol: The First Once-Daily Long-Acting Beta2 Agonist for Copd

Indacaterol: The First Once-Daily Long-Acting Beta2 Agonist for Copd

Hardcover

Series: Milestones in Drug Therapy

Medical Reference

ISBN10: 3034807082
ISBN13: 9783034807081
Publisher: Springer Nature
Published: Nov 27 2013
Pages: 146
Weight: 0.90
Height: 0.60 Width: 6.30 Depth: 9.20
Language: English

Current Pharmacotherapy for COPD.- The preclinical pharmacology of indacaterol.- The design of the indacaterol molecule.- The early clinical development of Indacaterol.- INHANCE: An adaptive confirmatory study with dose selection at interim.- Phase III clinical efficacy studies - lung function.- Phase III Clinical Efficacy of Indacaterol.- Patient-centered Outcomes.- The history and performance of the Breezhaler device.- What does the future hold for the therapy of COPD?

Also in

Medical Reference